“Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease,” by Carl Frieden and Kanchan Garai (Vol. 109, No. 23, Jun. 5, 2012, p. 8913-8918).
June 5, 2012
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
